Last edition
News about "hypertension "
AstraZeneca's Baxdrostat Achieves Significant Blood Pressure Reduction in Phase-III Study
The BaxHTN phase-III trial showed Baxdrostat, an investigational drug developed by AstraZeneca, significantly lowered systolic blood pressure in patients with hard-to-control hypertension, achieving both statistical and clinical relevance.
Hypertension | 01/09/2025 | By Dineshwori
Autonomix Secures New European Patent for Catheter-Based Technology
The newly issued ‘298 patent relates to the use of Autonomix’s proprietary technology to collect and process sensing data for real-time physiological monitoring.
Hypertension | 22/08/2025 | By Dineshwori
Zydus Gets Tentative Approval from USFDA for Azilsartan Medoxomil Tablets
Zydus Lifesciences Ltd. has secured a tentative approval from the United States Food and Drug Administration (USFDA) to market Azilsartan Medoxomil Tablets, 40 mg and 80 mg (USRLD: Edarbi tablets).
Hypertension | 06/07/2024 | By Aishwarya | 343
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy